Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease (DeCOG)

This study has been completed.
Information provided by (Responsible Party):
Prof. Dr. med. Dirk Schadendorf, University Hospital, Essen Identifier:
First received: December 29, 2010
Last updated: June 20, 2014
Last verified: June 2014